Report overview
Immunofluorescence is the specific antigen and antibody reaction where the antibodies are labeled with a fluorescent dye and the antigen-antibody complex is visualized using fluorescent (UV) microscope. Some of the commonly used fluorochromes include Acridine Orange, Lissamine, Rhodamine, and Calcofluor white. Various factors determine the type of immunofluorescence assay used such as time consumed, cost, complexity, flexibility, sensitivity, cross reactivity and many others. It is used in all disciplines of biology including medicine for diagnostics and research. Immunofluorescence assays are used to detect specific proteins in cells that may be in specimen, in culture, in tissues, on microbeads and microarrays, etc.
This report contains market size and forecasts of Immunofluorescence Assays in Global, including the following market information:
Global Immunofluorescence Assays Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Immunofluorescence Assays market was valued at 1727 million in 2021 and is projected to reach US$ 2224.8 million by 2028, at a CAGR of 3.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Immunofluorescence Assays include Thermo Fisher, Inova Diagnostics, Bio-Rad, Abcam, PerkinELmer, Merck Millipore, Cell Signaling Technology, MEDIPAN GMBH and Sino Biological, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Immunofluorescence Assays companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunofluorescence Assays Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Immunofluorescence Assays Market Segment Percentages, by Type, 2021 (%)
Antibodies
Kits and Reagents
Labeling Dyes
Global Immunofluorescence Assays Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Immunofluorescence Assays Market Segment Percentages, by Application, 2021 (%)
Clinical Research
Laboratory Diagnostics
Global Immunofluorescence Assays Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Immunofluorescence Assays Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunofluorescence Assays revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Immunofluorescence Assays revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher
Inova Diagnostics
Bio-Rad
Abcam
PerkinELmer
Merck Millipore
Cell Signaling Technology
MEDIPAN GMBH
Sino Biological
Danaher
Vector Laboratories
